Modeling of the metallic port in breast tissue expanders for photon radiotherapy

Jihyung Yoon, Yibo Xie, David Heins, Rui ZhangJournal of Applied Clinical Medical Physics 2018 · DOI

TL;DR

This paper addresses the critical need for accurate modeling of metallic ports in breast tissue expanders for radiotherapy. By developing and validating a new, generic model for these ports, the researchers significantly improved the accuracy of dose calculations in treatment planning systems, which is crucial for optimizing patient outcomes and minimizing complications.

What Problem Does This Paper Address?

Following mastectomy, many patients opt for immediate breast reconstruction using tissue expanders. These expanders often contain a high-density metallic injection port. When these patients require post-mastectomy radiotherapy (PMRT), the metallic port can significantly interfere with radiation dose calculations. Existing treatment planning systems (TPS) struggle to accurately model the complex interactions of high-density materials like these ports, leading to potential under- or over-dosing of critical tissues. Previous studies have yielded conflicting results regarding the dosimetric impact of these ports, highlighting the need for a reliable and validated model that can be universally applied.

Methods

The researchers developed a new model for the metallic port by first determining its physical dimensions through film measurements of transmitted beams. They then iteratively adjusted the density of this model within a commercial TPS (Pinnacle) until TPS calculations closely matched ion chamber (IC) measurements. This optimized model was then validated using a simplified anthropomorphic phantom and thermoluminescent dosimeters (TLDs). They compared their new model against two existing "clinical models" that represent common approaches to modeling these ports in TPS. Finally, they evaluated the impact of their model on dose calculations for a real patient's treatment plan.

Datasets

The study utilized measurements from:

  • Ion Chambers (IC): Used for initial density calibration of the metallic port model.
  • Thermoluminescent Dosimeters (TLDs): Used for validating the new model and comparing it with clinical models in a phantom setup.
  • Gafchromic EBT3 Film: Used to determine the physical dimensions of the metallic port.
  • Patient CT Images: Used to model the metallic port's location and orientation in a real patient case.

No new benchmark datasets were introduced; rather, existing measurement techniques were employed for validation.

Key Insights and Ideas

  • The "one-size-fits-all" problem: Existing TPS models for metallic ports are often based on specific manufacturer specifications or simplified assumptions, leading to inconsistent and inaccurate dose calculations.
  • Density is key, but not the only factor: While density is crucial for modeling high-Z materials, the precise dimensions and how the TPS handles beam interactions (e.g., scatter, attenuation) at the interface are equally important.
  • Clinical models can be misleading: The study demonstrated that commonly used clinical modeling approaches can either overestimate or underestimate the dose perturbation caused by the metallic port, potentially leading to suboptimal treatment.
  • A generic, validated model is achievable: The researchers successfully created a generic model with specific dimensions and density that showed good agreement with measurements across different beam energies and setups, suggesting it can be broadly applied.

Key Results

  • The optimized metallic port model had dimensions of 1.75 cm in diameter and 5 mm in thickness, with a density of 7.5 g/cm³.
  • TPS calculations using the new model showed good agreement with IC measurements (within 1%) and TLD measurements (within 5.0%) in phantom studies.
  • The new model demonstrated superior accuracy compared to two existing clinical models in phantom studies.
  • For a real patient case, the metallic port had a negligible impact on the chest wall dose but introduced significant dose shadows in the skin area, particularly with conventional treatment plans.
  • The new model's accuracy is expected to improve dose delivery for PMRT patients with tissue expanders, potentially reducing complications.

Limitations and Future Work

  • Limited to one TPS: The model was developed and validated for the Pinnacle TPS. While Pinnacle is widely used, the methodology might need adaptation for other TPS platforms.
  • Single expander type: The study focused on one specific type of tissue expander (McGhan Style 133). While this is a popular model, other brands exist, and their ports might have slightly different characteristics.
  • Limited patient cases: Only one patient's treatment plans were evaluated for clinical relevance.
  • Future Work: The authors suggest that the methodology used in this study can be extended to investigate other high-density materials encountered in radiotherapy, such as metal implants in patients with chordoma, pacemakers, or dental implants. They also highlight the potential for this work to improve treatment planning for patients with temporary tissue expanders, reducing the risk of complications.

Summary updated

Abstract

The purpose of this study was to model the metallic port in breast tissue expanders and to improve the accuracy of dose calculations in a commercial photon treatment planning system (TPS). The density of the model was determined by comparing TPS calculations and ion chamber (IC) measurements. The model was further validated and compared with two widely used clinical models by using a simplified anthropomorphic phantom and thermoluminescent dosimeters (TLD) measurements. Dose perturbations and target coverage for a single postmastectomy radiotherapy (PMRT) patient were also evaluated. The dimensions of the metallic port model were determined to be 1.75 cm in diameter and 5 mm in thickness. The density of the port was adjusted to be 7.5 g/cm<sup>3</sup> which minimized the differences between IC measurements and TPS calculations. Using the simplified anthropomorphic phantom, we found the TPS calculated point doses based on the new model were in agreement with TLD measurements within 5.0% and were more accurate than doses calculated based on the clinical models. Based on the photon treatment plans for a real patient, we found that the metallic port has a negligible dosimetric impact on chest wall, while the port introduced significant dose shadow in skin area. The current clinical port models either overestimate or underestimate the attenuation from the metallic port, and the dose perturbation depends on the plan and the model in a complex way. TPS calculations based on our model of the metallic port showed good agreement with measurements for all cases. This new model could improve the accuracy of dose calculations for PMRT patients who have temporary tissue expanders implanted during radiotherapy and could potentially reduce the risk of complications after the treatment.
BibTeX
@article{yoon2018modeling,
  author = {Jihyung Yoon and Yibo Xie and David Heins and Rui Zhang},
  title = {{Modeling of the metallic port in breast tissue expanders for photon radiotherapy}},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2018},
  doi = {10.1002/acm2.12320},
}
Figure